Colds and flu are the most common infections in our modern world. These respiratory tract infections can have significant healthcare consequences such as exacerbation of asthma or bronchitis, as well as the impact of flu on vulnerable members of the population.

Echinacea is a popular ingredient used to treat colds and flu in many parts of the world and also one of our most widely researched herbs. With the recent discovery of anti-viral, anti-inflammatory, and immune-modulating activity, there has been renewed interest in clinical research.

In this conference, data will be presented from the very latest and largest Echinacea clinical study, as well as a review of current knowledge on the herb. The panel of expert speakers will give first-hand access to research data and offer discussion on the role of Echinacea in today’s primary healthcare.

There is no charge for entrance to the conference. For more information, please contact:

Eileen Sheets
Bioforce USA
800-641-7555 x100
esheets@bioforceusa.com